GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Other Net Income (Loss)

Cantourage Group SE (XTER:HIGH) Other Net Income (Loss) : €-0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Other Net Income (Loss)?

Cantourage Group SE's Other Net Income (Loss) for the six months ended in Jun. 2023 was €-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.00 Mil.

Cantourage Group SE's quarterly Other Net Income (Loss) stayed the same from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) but then declined from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€-0.00 Mil).

Cantourage Group SE's annual Other Net Income (Loss) stayed the same from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil) but then declined from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€-0.00 Mil).

Cantourage Group SE Other Net Income (Loss) Historical Data

The historical data trend for Cantourage Group SE's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Other Net Income (Loss) Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Other Net Income (Loss)
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Other Net Income (Loss) Get a 7-Day Free Trial - - - - -

Cantourage Group SE Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantourage Group SE (XTER:HIGH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Other Net Income (Loss)
Comparable Companies
Traded in Other Exchanges
HIGH:Germany
Address
Feurigstrasse 54, Berlin, DEU, 10827
Website
https://www.cantourage.com
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines